Annual CFI
$7.30 M
-$34.53 M-82.56%
December 31, 2023
Summary
- As of February 7, 2025, IMRX annual cash flow from investing activities is $7.30 million, with the most recent change of -$34.53 million (-82.56%) on December 31, 2023.
- During the last 3 years, IMRX annual CFI has risen by +$7.35 million (+13763.86%).
- IMRX annual CFI is now -82.56% below its all-time high of $41.83 million, reached on December 31, 2022.
Performance
IMRX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$5.42 M
-$10.38 M-209.02%
September 30, 2024
Summary
- As of February 7, 2025, IMRX quarterly cash flow from investing activities is -$5.42 million, with the most recent change of -$10.38 million (-209.02%) on September 30, 2024.
- Over the past year, IMRX quarterly CFI has dropped by -$26.81 million (-125.31%).
- IMRX quarterly CFI is now -124.44% below its all-time high of $22.15 million, reached on June 30, 2022.
Performance
IMRX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$24.08 M
+$18.56 M+336.11%
September 30, 2024
Summary
- As of February 7, 2025, IMRX TTM cash flow from investing activities is $24.08 million, with the most recent change of +$18.56 million (+336.11%) on September 30, 2024.
- Over the past year, IMRX TTM CFI has increased by +$14.36 million (+147.78%).
- IMRX TTM CFI is now -50.25% below its all-time high of $48.40 million, reached on March 31, 2023.
Performance
IMRX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
IMRX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -82.6% | -125.3% | +147.8% |
| 3 y3 years | +10000.0% | -166.4% | -42.4% |
| 5 y5 years | +10000.0% | -166.4% | -42.4% |
IMRX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -82.6% | +109.7% | -124.4% | +77.4% | -50.3% | +131.8% |
| 5 y | 5-year | -82.6% | +109.7% | -124.4% | +89.7% | -50.3% | +131.8% |
| alltime | all time | -82.6% | +109.7% | -124.4% | +89.7% | -50.3% | +131.8% |
Immuneering Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.42 M(-209.0%) | $24.08 M(+336.1%) |
| Jun 2024 | - | $4.97 M(-76.8%) | $5.52 M(-43.2%) |
| Mar 2024 | - | $21.39 M(+582.8%) | $9.72 M(+33.2%) |
| Dec 2023 | $7.30 M(-82.6%) | $3.13 M(-113.1%) | $7.30 M(-40.8%) |
| Sep 2023 | - | -$23.97 M(-361.6%) | $12.32 M(-65.2%) |
| Jun 2023 | - | $9.16 M(-51.7%) | $35.41 M(-26.8%) |
| Mar 2023 | - | $18.97 M(+132.7%) | $48.40 M(+15.7%) |
| Dec 2022 | $41.83 M | $8.15 M(-1026.3%) | $41.83 M(+284.8%) |
| Sep 2022 | - | -$880.10 K(-104.0%) | $10.87 M(-126.5%) |
| Jun 2022 | - | $22.15 M(+78.6%) | -$41.02 M(-35.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $12.40 M(-154.4%) | -$63.19 M(-16.4%) |
| Dec 2021 | -$75.62 M(>+9900.0%) | -$22.81 M(-56.8%) | -$75.62 M(+43.1%) |
| Sep 2021 | - | -$52.77 M(>+9900.0%) | -$52.85 M(>+9900.0%) |
| Jun 2021 | - | -$19.80 K(+19.3%) | -$80.10 K(+21.9%) |
| Mar 2021 | - | -$16.60 K(-56.4%) | -$65.70 K(+23.0%) |
| Dec 2020 | -$53.40 K(+160.5%) | -$38.10 K(+580.4%) | -$53.40 K(+249.0%) |
| Sep 2020 | - | -$5600.00(+3.7%) | -$15.30 K(+57.7%) |
| Jun 2020 | - | -$5400.00(+25.6%) | -$9700.00(+125.6%) |
| Mar 2020 | - | -$4300.00 | -$4300.00 |
| Dec 2019 | -$20.50 K | - | - |
FAQ
- What is Immuneering annual cash flow from investing activities?
- What is the all time high annual CFI for Immuneering?
- What is Immuneering annual CFI year-on-year change?
- What is Immuneering quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Immuneering?
- What is Immuneering quarterly CFI year-on-year change?
- What is Immuneering TTM cash flow from investing activities?
- What is the all time high TTM CFI for Immuneering?
- What is Immuneering TTM CFI year-on-year change?
What is Immuneering annual cash flow from investing activities?
The current annual CFI of IMRX is $7.30 M
What is the all time high annual CFI for Immuneering?
Immuneering all-time high annual cash flow from investing activities is $41.83 M
What is Immuneering annual CFI year-on-year change?
Over the past year, IMRX annual cash flow from investing activities has changed by -$34.53 M (-82.56%)
What is Immuneering quarterly cash flow from investing activities?
The current quarterly CFI of IMRX is -$5.42 M
What is the all time high quarterly CFI for Immuneering?
Immuneering all-time high quarterly cash flow from investing activities is $22.15 M
What is Immuneering quarterly CFI year-on-year change?
Over the past year, IMRX quarterly cash flow from investing activities has changed by -$26.81 M (-125.31%)
What is Immuneering TTM cash flow from investing activities?
The current TTM CFI of IMRX is $24.08 M
What is the all time high TTM CFI for Immuneering?
Immuneering all-time high TTM cash flow from investing activities is $48.40 M
What is Immuneering TTM CFI year-on-year change?
Over the past year, IMRX TTM cash flow from investing activities has changed by +$14.36 M (+147.78%)